Navigation Links
Insmed Announces First Quarter 2008 Financial Results
Date:5/8/2008

Adjustments to reconcile net loss to net cash

used in operating activities:

Depreciation and amortization 292 82

Stock based compensation expense 133 56

Stock options issued for services - 8

Changes in operating assets and liabilities:

Accounts receivable (77) 130

Inventory - 576

Other assets 134 52

Accounts payable (100) (2,936)

Accrued project costs 12 (547)

Payroll liabilities 168 812

Deferred income 26 -

Asset retirement obligation - 147

Interest payable (3) -

Net cash used in operating activities (4,288) (11,873)

Investing activities

Decreases (increases) of short-term investments 5,601 12,044

Purchases of investments - (500)

Realized loss on investments 392 -

Net cash provided by investing activities 5,993 11,544

Financing activities

Repayment of convertible notes (553) -

Cash restricted to restricted letters of credit - 297

Net cash (used in) provided by financing activities (553) 297

Increase (decrease) in cash and cash equivalents 1,152 (32)

Cash and cash equivalents at beginning of period 3,554 2,121

Cash and cash equivalents at end of period $4,70
'/>"/>

SOURCE Insmed Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Insmed Appoints Dennis M. Lanfear to Board Of Directors
2. Insmed Awarded $2.1 Million by Muscular Dystrophy Association
3. Insmed to Appeal Delisting Notification From Nasdaq
4. Insmed President Interviewed for Follow-On Biologics Podcast: Insmed Inc. President Steve Glover Discusses Safe and Effective Biologic Therapies and Reduced Costs with The American Magazine
5. Insmed CEO Issues Statement on White House FY09 Budget and FDA Statements on Follow-On Biologics
6. Insmed to Host Fourth Quarter and Full-Year 2007 Conference Call
7. Insmed Announces Listing Transfer from Nasdaq Global Market to Nasdaq Capital Market
8. Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results
9. Insmed Announces Additional Information in Compliance With NASDAQ Rules
10. Insmed Selected to Complete Congressional Questionnaire Regarding the Potential Establishment of a Follow-On Biologics Regulatory Pathway
11. Insmed to Present at CBI Follow-On Biologics Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...REYKJAVIK,Iceland,November24/PRNewswire-FirstCall/...dtheapprovalofallofits,"firstday"motionsbytheU.S.B...ptcyCourt").deCODElastweekfiledavoluntarypetitionf...Codewiththe,BankruptcyCourt. , Theordersissue...perateitsbusinessduringtheChapter11proceedings.Inp...
(Date:11/24/2009)...SHANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxya...n(SFDA)hasapprovedthe,investigationalnewdrugapplic...vativeinsulinformulationtotreatdiabetes.ThisIND,ap...lstudy. , Diabetesisadisordercharacteristicof...sofdiabetesoftenresultinseveremicro-and,macro-vasc...
(Date:11/24/2009)...Primaryefficacyendpointhasbeenmetforpatientswithad...QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZen...obalbiopharmaceuticalcompanyfocusedonendocrinether...romaPhase2studywithitstargetedcytotoxicpeptideconj...cedorrecurrentendometrialcancer.Inapersonalizedhea...
(Date:11/24/2009)...SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaP...thatthecompanyisscheduledtopresentatthePiperJaffra...1:30a.m.EasternTime(8:30a.m.PacificTime)attheNewYo...ent andChiefExecutiveOfficer,isscheduledtoprovidea...entanddiscoveryprograms. ,, Aliveaudiowebcastof...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...C., April 2 Chimerix, Inc., a biotechnology compa...ics, announced today that the Company has joined t...work of public-private partnerships to discover, d...ve and affordable antimalarial drugs. The MMV will...ivity against malaria, and any lead candidates tha...
...lution A/S today announced that Merck & Co. In...e collaboration agreement announced in June 2008 t...g discovery technology to identify novel small mol...entering the second phase, Merck gains access to a...mall molecule drug candidates. In addition, this ...
... /PRNewswire-Asia-FirstCall/ -- China Biologic,Pro...logic" or the "Company"),one of the leading plasma...public of China ("PRC"), reported financial result...8 Highlights, -- Revenues increased 44.3% year-...rofit increased 45.7% to $32.7 million over 2007, ...
Other Biology Technology:Chimerix Joins International Network of Organizations to Cure Malaria 2Chimerix Joins International Network of Organizations to Cure Malaria 3Nuevolution Announces Progress in Its Collaboration With Merck & Co. Inc. 2China Biologic Products Announces Strong 2008 Results 2China Biologic Products Announces Strong 2008 Results 3China Biologic Products Announces Strong 2008 Results 4China Biologic Products Announces Strong 2008 Results 5China Biologic Products Announces Strong 2008 Results 6China Biologic Products Announces Strong 2008 Results 7China Biologic Products Announces Strong 2008 Results 8China Biologic Products Announces Strong 2008 Results 9China Biologic Products Announces Strong 2008 Results 10China Biologic Products Announces Strong 2008 Results 11China Biologic Products Announces Strong 2008 Results 12China Biologic Products Announces Strong 2008 Results 13China Biologic Products Announces Strong 2008 Results 14China Biologic Products Announces Strong 2008 Results 15
(Date:11/24/2009)...ambridge, Md. (November 24, 2009) New research on... river ecosystems reveals predictable temporal pat...communities as markers for monitoring climate chan... week in the Proceedings of the National Academy ...ommunities in the six rivers shifted synchronously...
(Date:11/23/2009)... TORONTO, November 23, 2009 - The time of day matt...g to a new paper produced by a research team led b...o Scarborough,s vice-principal for research and co...logy at the St. George campus. , Capitalizing ... poplar tree, the research team examined how popla...
(Date:11/23/2009)... AMES, Iowa - The only swine vaccine available for... herd infected with the virus. The vaccination mar... herd diagnosed with the pandemic flu., Iowa Sta...cience, developed the vaccine this summer and has ...in Iowa, Kansas and Illinois for several weeks., ...
Breaking Biology News(10 mins):Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2Time of day matters to thirsty trees, U of T researcher discovers 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 1Glucose metabolism and recidivism of severe violent crimes in alcohol intoxications 47468 2New study finds lowfat chocolate milk is effective post exercise recovery aid for soccer players 8670 1New study finds lowfat chocolate milk is effective post exercise recovery aid for soccer players 8670 2Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 1Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 2Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 3Survey Reveals Injectable Procedures Are Mainstream And Accepted Medical Aesthetic Treatment Options 47464 4
...at the University of Massachusetts Medical School ...es the ability of scientists to target individual ...tial implications for both basic science research ...ne led by Scot A. Wolfe, PhD, an assistant profess...d the Department of Biochemistry & Molecular Pharm...
...ity Medical Centre (LUMC) are the first to determi...rst European whose DNA sequence has been determine... morning, during a special press conference at Bes...ss in the Netherlands. , Following in-depth ana...cidental privacy-sensitive findings. The results w...
...e discovered a new strategy for an immunization ag...d that immune cells react strongly to the modified...ect has occurred. It is estimated that this repair...rs. , The researchers, led by Professor Dr. Mag...Department of Applied Tumor Biology at the Heidelb...
Other Biology News:New technique allows targeted inactivation of genes in research model 2Leiden scientists sequence first female DNA 2To fight the cancer before the tumor grows 2
...zers , Ultima II Series ,Developed for t...sents the finest, most enhanced ultra-low freezer ...ank configurations, each Ultima II freezer include...m with built-in voltage boost and surge suppressor...
SkanIt Software for Varioskan, Drug Discovery Edition from Thermo Scientific
Bsu36 I from Promega
Multiskan EX from Thermo Scientific
Biology Products: